Injective’s Growth Fuels Optimism for Breakout, $INJ ETF nears approval

Injective’s TVL surged by 77% in August, exceeding $34 million. This growth is attributed to increased DeFi activity and growing institutional interest. The platform’s RWA perpetuals volume has risen by a remarkable 1,400% since January, indicating strong demand for its products. Analysts are closely watching the upcoming SEC comment period regarding the Injective’s ETF, which could boost investor confidence and propel price increases.